Cargando…

HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism

Upon severe DNA damage a cellular signalling network initiates a cell death response through activating tumour suppressor p53 in association with promyelocytic leukaemia (PML) nuclear bodies. The deacetylase Sirtuin 1 (SIRT1) suppresses cell death after DNA damage by antagonizing p53 acetylation. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Conrad, E, Polonio-Vallon, T, Meister, M, Matt, S, Bitomsky, N, Herbel, C, Liebl, M, Greiner, V, Kriznik, B, Schumacher, S, Krieghoff-Henning, E, Hofmann, T G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815982/
https://www.ncbi.nlm.nih.gov/pubmed/26113041
http://dx.doi.org/10.1038/cdd.2015.75
_version_ 1782424650708418560
author Conrad, E
Polonio-Vallon, T
Meister, M
Matt, S
Bitomsky, N
Herbel, C
Liebl, M
Greiner, V
Kriznik, B
Schumacher, S
Krieghoff-Henning, E
Hofmann, T G
author_facet Conrad, E
Polonio-Vallon, T
Meister, M
Matt, S
Bitomsky, N
Herbel, C
Liebl, M
Greiner, V
Kriznik, B
Schumacher, S
Krieghoff-Henning, E
Hofmann, T G
author_sort Conrad, E
collection PubMed
description Upon severe DNA damage a cellular signalling network initiates a cell death response through activating tumour suppressor p53 in association with promyelocytic leukaemia (PML) nuclear bodies. The deacetylase Sirtuin 1 (SIRT1) suppresses cell death after DNA damage by antagonizing p53 acetylation. To facilitate efficient p53 acetylation, SIRT1 function needs to be restricted. How SIRT1 activity is regulated under these conditions remains largely unclear. Here we provide evidence that SIRT1 activity is limited upon severe DNA damage through phosphorylation by the DNA damage-responsive kinase HIPK2. We found that DNA damage provokes interaction of SIRT1 and HIPK2, which phosphorylates SIRT1 at Serine 682 upon lethal damage. Furthermore, upon DNA damage SIRT1 and HIPK2 colocalize at PML nuclear bodies, and PML depletion abrogates DNA damage-induced SIRT1 Ser682 phosphorylation. We show that Ser682 phosphorylation inhibits SIRT1 activity and impacts on p53 acetylation, apoptotic p53 target gene expression and cell death. Mechanistically, we found that DNA damage-induced SIRT1 Ser682 phosphorylation provokes disruption of the complex between SIRT1 and its activator AROS. Our findings indicate that phosphorylation-dependent restriction of SIRT1 activity by HIPK2 shapes the p53 response.
format Online
Article
Text
id pubmed-4815982
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48159822016-04-13 HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism Conrad, E Polonio-Vallon, T Meister, M Matt, S Bitomsky, N Herbel, C Liebl, M Greiner, V Kriznik, B Schumacher, S Krieghoff-Henning, E Hofmann, T G Cell Death Differ Original Paper Upon severe DNA damage a cellular signalling network initiates a cell death response through activating tumour suppressor p53 in association with promyelocytic leukaemia (PML) nuclear bodies. The deacetylase Sirtuin 1 (SIRT1) suppresses cell death after DNA damage by antagonizing p53 acetylation. To facilitate efficient p53 acetylation, SIRT1 function needs to be restricted. How SIRT1 activity is regulated under these conditions remains largely unclear. Here we provide evidence that SIRT1 activity is limited upon severe DNA damage through phosphorylation by the DNA damage-responsive kinase HIPK2. We found that DNA damage provokes interaction of SIRT1 and HIPK2, which phosphorylates SIRT1 at Serine 682 upon lethal damage. Furthermore, upon DNA damage SIRT1 and HIPK2 colocalize at PML nuclear bodies, and PML depletion abrogates DNA damage-induced SIRT1 Ser682 phosphorylation. We show that Ser682 phosphorylation inhibits SIRT1 activity and impacts on p53 acetylation, apoptotic p53 target gene expression and cell death. Mechanistically, we found that DNA damage-induced SIRT1 Ser682 phosphorylation provokes disruption of the complex between SIRT1 and its activator AROS. Our findings indicate that phosphorylation-dependent restriction of SIRT1 activity by HIPK2 shapes the p53 response. Nature Publishing Group 2016-01 2015-06-26 /pmc/articles/PMC4815982/ /pubmed/26113041 http://dx.doi.org/10.1038/cdd.2015.75 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Original Paper
Conrad, E
Polonio-Vallon, T
Meister, M
Matt, S
Bitomsky, N
Herbel, C
Liebl, M
Greiner, V
Kriznik, B
Schumacher, S
Krieghoff-Henning, E
Hofmann, T G
HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism
title HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism
title_full HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism
title_fullStr HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism
title_full_unstemmed HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism
title_short HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism
title_sort hipk2 restricts sirt1 activity upon severe dna damage by a phosphorylation-controlled mechanism
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815982/
https://www.ncbi.nlm.nih.gov/pubmed/26113041
http://dx.doi.org/10.1038/cdd.2015.75
work_keys_str_mv AT conrade hipk2restrictssirt1activityuponseverednadamagebyaphosphorylationcontrolledmechanism
AT poloniovallont hipk2restrictssirt1activityuponseverednadamagebyaphosphorylationcontrolledmechanism
AT meisterm hipk2restrictssirt1activityuponseverednadamagebyaphosphorylationcontrolledmechanism
AT matts hipk2restrictssirt1activityuponseverednadamagebyaphosphorylationcontrolledmechanism
AT bitomskyn hipk2restrictssirt1activityuponseverednadamagebyaphosphorylationcontrolledmechanism
AT herbelc hipk2restrictssirt1activityuponseverednadamagebyaphosphorylationcontrolledmechanism
AT lieblm hipk2restrictssirt1activityuponseverednadamagebyaphosphorylationcontrolledmechanism
AT greinerv hipk2restrictssirt1activityuponseverednadamagebyaphosphorylationcontrolledmechanism
AT kriznikb hipk2restrictssirt1activityuponseverednadamagebyaphosphorylationcontrolledmechanism
AT schumachers hipk2restrictssirt1activityuponseverednadamagebyaphosphorylationcontrolledmechanism
AT krieghoffhenninge hipk2restrictssirt1activityuponseverednadamagebyaphosphorylationcontrolledmechanism
AT hofmanntg hipk2restrictssirt1activityuponseverednadamagebyaphosphorylationcontrolledmechanism